Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2022.
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Mumbai (Maharashtra) [India]/ Mahwah (New Jersey) [US], June 28 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharmaceutical company, announced that its fully owned subsidiary Glenmark Pharmaceuticals Inc., USA (Glenmark) has acquired the approved Abbreviated
Mumbai (Maharashtra) [India], May 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.
Mumbai (Maharashtra) [India], May 28 (ANI): Glenmark Pharmaceuticals Limited on Saturday reported a net consolidated profit of Rs 172.6 crore for the quarter ended March 2022 as compared to Rs 234 crore recorded in the corresponding period of the last year, registering a decline of 26 per ce
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists
Mumbai (Maharashtra) [India], May 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytiga®1 Tablets, 500 mg, of J
Mumbai (Maharashtra) [India], May 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent, the gen
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, a
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (